Remarks from Anna Abram as prepared for delivery to the 2018 Intergovermental Meeting on Drug Compounding
Remarks by FDA’s Anna Abram to the 2018 Intergovermental Meeting on Drug Compounding
Remarks by FDA’s Anna Abram to the 2018 Intergovermental Meeting on Drug Compounding